John Rawles Wuchenich, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Loma Linda University School of Medicine, 2010
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wuchenich’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A162333 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · Loma Linda University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$19,940
Medicare paid this office $19,940 for 132 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 75 | $9,004 | $67 |
| Short return visit (20+ min) | 57 | $3,390 | $50 |
| Return visit (30+ min) | 23 | $2,532 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 53 | $1,046 | $15 |
| Short return visit (20+ min) | 16 | $1,038 | $65 |
See all 7 services
| Return visit (30+ min) | 75 | $9,004 | $67 |
| Short return visit (20+ min) | 57 | $3,390 | $50 |
| Return visit (30+ min) | 23 | $2,532 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 53 | $1,046 | $15 |
| Short return visit (20+ min) | 16 | $1,038 | $65 |
| New patient visit (45+ min) | 12 | $1,025 | $85 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 14 | $209 | $15 |
Who their Medicare patients are
132 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 10% · Women 52% · Also on Medicaid 23% · Health risk score 1.45. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 58% · Diabetes 27% · Cancer 20% · Coronary heart disease 19% · Chronic kidney disease 19% · Depression 18% · Heart failure 17% · Atrial fibrillation 14% · Dementia 10%.
The office billed $76,149, Medicare allowed $28,468 and paid $19,940; for 367 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 132 | 367 | 73 | 1.45 | $76,149 | $19,940 |
| 2023 | 41 | 67 | 74 | 1.04 | $14,004 | $4,879 |
| 2018 | 35 | 94 | 67 | 3.57 | $20,065 | $6,198 |
| 2017 | 223 | 559 | 71 | 2.84 | $125,633 | $40,527 |
| 2016 | 305 | 842 | 71 | 2.97 | $190,934 | $62,852 |
| 2015 | 91 | 242 | 72 | 2.90 | $48,693 | $16,211 |
| 2014 | 37 | 46 | 79 | 1.86 | $6,868 | $3,296 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 32 | $3,255 | $71 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,512 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,311 | $82 |
| Hospital discharge day management, more than 30 minutes | 11 | $790 | $72 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $12,234 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $8,240 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,306 | $152 |
| Hospital discharge day management, more than 30 minutes | 51 | $4,159 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,954 | $103 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,540 | $30 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,245 | $57 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 125 | $21,660 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 115 | $12,322 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $10,554 | $153 |
| Hospital discharge day management, more than 30 minutes | 91 | $7,612 | $83 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $2,101 | $29 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,539 | $140 |
| Follow-up observation care per day, typically 25 minutes | 18 | $1,437 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,088 | $99 |
| Hospital observation care on day of discharge | 15 | $825 | $55 |
| Hospital discharge day management, 30 minutes or less | 11 | $620 | $56 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $5,976 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $4,055 | $81 |
| Hospital discharge day management, more than 30 minutes | 20 | $1,680 | $84 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $916 | $57 |
Drugs they prescribed that Part D paid
$79,360
Pharmacies billed $79,360 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (47 of 638) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%. Long-acting opioids: 23% of their opioid prescriptions.
562 generic and fewer than 11 brand-name prescriptions · $79,360 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 16 | $22,702 | $1,419 |
| Hydrocodone-Acetaminophen | 13 | $739 | $57 |
| Valacyclovir | 11 | $584 | $53 |
| Duloxetine | 16 | $423 | $26 |
| Atorvastatin | 28 | $293 | $10 |
See all 17 drugs
| Jardiance | 16 | $22,702 | $1,419 |
| Hydrocodone-Acetaminophen | 13 | $739 | $57 |
| Valacyclovir | 11 | $584 | $53 |
| Duloxetine | 16 | $423 | $26 |
| Atorvastatin | 28 | $293 | $10 |
| Levothyroxine | 21 | $284 | $14 |
| Methadone | 11 | $280 | $25 |
| Losartan | 28 | $278 | $10 |
| Metoprolol | 14 | $253 | $18 |
| Rosuvastatin | 15 | $199 | $13 |
| Gabapentin | 22 | $185 | $8 |
| Pravastatin | 11 | $172 | $16 |
| Omeprazole | 15 | $134 | $9 |
| Metformin | 13 | $113 | $9 |
| Clonazepam | 22 | $106 | $5 |
| Amlodipine Besylate | 16 | $96 | $6 |
| Furosemide | 12 | $19 | $2 |
Year by year
| 2024 | 638 | 113 | 7% (47) | None | $79,360 |
| 2023 | 163 | 44 | 12% (20) | None | $12,917 |
| 2022 | 149 | None | 0% (0) | None | $7,169 |
| 2021 | 49 | None | 0% (0) | None | $6,324 |
| 2018 | 47 | 32 | 36% (17) | None | $6,204 |
| 2017 | 140 | 57 | 9% (12) | 13% | $10,008 |
| 2016 | 265 | 116 | 7% (19) | 14% | $7,797 |
| 2015 | 138 | 41 | None | 15% | $6,742 |
| 2014 | 117 | 11 | None | 29% | $12,313 |
| 2013 | 120 | 22 | 12% (14) | None | $9,173 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 6 drugs
| Memantine | 14 | $2,225 | $159 |
| Mirtazapine | 12 | $479 | $40 |
| Levothyroxine | 19 | $189 | $10 |
| Quetiapine | 11 | $73 | $7 |
| Amlodipine Besylate | 12 | $65 | $5 |
| Losartan | 11 | $63 | $6 |
2016: 3 drugs
| Prednisone | 31 | $157 | $5 |
| Atorvastatin | 12 | $142 | $12 |
| Furosemide | 12 | $64 | $5 |
2015: 1 drug
| Lisinopril | 13 | $74 | $6 |
2014: 1 drug
| Citalopram Hbr | 11 | $136 | $12 |
Money from drug and device companies
$22 in 2021
A payment is not proof that care is biased.
| Lilly USA | Baqsimi | $22 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2021-03-17 | Baqsimi | $22 |
Professional record
- NPI
- 1144549973
- Licence
- CA A162333California A162333: Current · expires 2027-05-31
- Trained
- Loma Linda University School of Medicine, 2010 · 16 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-05-18
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.